14 / 25
Page 38
Notes:
conferenceseries
.com
Volume 8
Journal of Clinical Trials
Pharmacy and Pharmacovigilance 2018
July 16-17, 2018
July 16-17, 2018 Sydney, Australia
Joint Event on
Global Pharmacovigilance and
Advanced Pharmacy
The association between cardiorespiratory fitness and physical activity levels of central obese adults
in Enugu State (eastern part), Nigeria
Iwezu Happy Nonso
University of Nigeria Nsukka, Nigeria
C
entral obesity and its implicated adverse health conditions are a major concern of some people. Central obesity is one of the
predisposition factors to cardiovascular disease, respiratory conditions, type-2 diabetes mellitus, cancer and others. The purpose
of this study was to determine the relationship between central obesity, cardiorespiratory fitness and physical activity level among
adults in Enugu State. 317 subjects (158 obese and 159 non obese) who met the inclusion criteria and gave their informed consent
participated in the study. Their waist to hip ratio was determined using measuring tape. Body mass index is measured with stadiometer
and weighing scale. Cardiorespiratory fitness was determined using Harvard step test and International Physical Activity Questionnaire
(IPAQ) was used to determine their physical activity level. Data collected was analyzed descriptively and inferentially using correlation
test. The level of significance was set at p=0.01. The physical activity level of obese adults in Enugu state increases in an ascending order
of vigorous, low, moderate while the cardiorespiratory fitness decreases in reverse direction as low, average, good, excellence and very
low. There was a significant relationship between cardiorespiratory fitness and physical activity (r=0.146, sig=0.009). There was also a
significant relationship between waist-hip ratio and cardiorespiratory fitness (r=-0.221, sig=0.000). In this seminar, I will discuss the
effect of central obesity on cardiorespiratory fitness and physical activity on adults and its pathophysiology.
iwezuhappy@yahoo.comJ Clin Trials 2018, Volume 8
DOI: 10.4172/2167-0870-C2-026